(Nasdaq: MYOK), today reported financial results ... Executive Director, Corporate Communications and Investor Relations ... Stern Investor Relations, Inc. 212-362- ...
People also ask
What is the revenue of MyoKardia?
Who is the founder of MyoKardia?
Who owns Mavacamten?
What is the medication for MyoKardia?
Sep 11, 2020 · Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects.
Missing: relations | Show results with:relations
Ticker MYOK. Exchange NASDAQ More. Industry ... Myokardia Inc reports have an aggregate usefulness score of 4.8 based on 92 reviews. ... Older/Archived Annual ...
Missing: investor relations
(Nasdaq: MYOK) today reported financial results ... Investor Relations contact at ir@myokardia.com. ... Stern Investor Relations, Inc. 212-362-1200. hannah ...
Oct 5, 2020 · Bristol Myers Squibb to Acquire MyoKardia for $13.1 Billion in Cash ; Investors: Tim Power, 609-252-7509, timothy.power@bms.com. Nina Goworek, ...
Oct 5, 2020 · Investors and MyoKardia stockholders are strongly advised to read the tender offer statement (including an offer to purchase, letter of ...
Missing: relations | Show results with:relations
Aug 11, 2020 · Pioneering a Precision Approach to Cardiovascular Medicine Corporate Presentation - August 2020 forward-looking statement ...
Investor FAQs · Email Alerts · Contact Us · Investor Relations. News Release Details. Facebook; Twitter · Email · Tumblr · LinkedIn · News & Events · Stock ...
Bristol Myers Squibb has agreed to acquire MyoKardia, a clinical-stage biopharmaceutical company discovering and developing targeted therapies for the ...
Real-time Price Updates for Myokardia Inc (MYOK-Q), along with buy or sell indicators, analysis, charts, historical performance, news and more.
Missing: relations | Show results with:relations